Lifesci Capital Issues Pessimistic Outlook for SLNO Earnings
Soleno Therapeutics, Inc. (NASDAQ:SLNO – Free Report) – Research analysts at Lifesci Capital lowered their Q1 2025 EPS estimates for shares of Soleno Therapeutics in a research report issued to clients and investors on Thursday, March 27th. Lifesci Capital analyst M. Belghiti now expects that the company will earn ($1.46) per share for the quarter, […]
Soleno Therapeutics, Inc. (NASDAQ:SLNO – Free Report) – Research analysts at Lifesci Capital lowered their Q1 2025 EPS estimates for shares of Soleno Therapeutics in a research report issued to clients and investors on Thursday, March 27th. Lifesci Capital analyst M. Belghiti now expects that the company will earn ($1.46) per share for the quarter, […]
